Unlocking the crucial role of cancer-associated fibroblasts in tumor metastasis: Mechanisms and therapeutic prospects
- PMID: 38825314
- PMCID: PMC12126706
- DOI: 10.1016/j.jare.2024.05.031
Unlocking the crucial role of cancer-associated fibroblasts in tumor metastasis: Mechanisms and therapeutic prospects
Abstract
Background: Tumor metastasis represents a stepwise progression and stands as a principal determinant of unfavorable prognoses among cancer patients. Consequently, an in-depth exploration of its mechanisms holds paramount clinical significance. Cancer-associated fibroblasts (CAFs), constituting the most abundant stromal cell population within the tumor microenvironment (TME), have garnered robust evidence support for their pivotal regulatory roles in tumor metastasis.
Aim of review: This review systematically explores the roles of CAFs at eight critical stages of tumorigenic dissemination: 1) extracellular matrix (ECM) remodeling, 2) epithelial-mesenchymal transition (EMT), 3) angiogenesis, 4) tumor metabolism, 5) perivascular migration, 6) immune escape, 7) dormancy, and 8) premetastatic niche (PMN) formation. Additionally, we provide a compendium of extant strategies aimed at targeting CAFs in cancer therapy.
Key scientific concepts of review: This review delineates a structured framework for the interplay between CAFs and tumor metastasis while furnishing insights for the potential therapeutic developments. It contributes to a deeper understanding of cancer metastasis within the TME, facilitating the utilization of CAF-targeting therapies in anti-metastatic approaches.
Keywords: Cancer-associated fibroblasts; Metastasis; Therapy; Tumor microenvironment.
Copyright © 2024. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures






Similar articles
-
Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.OMICS. 2020 Jun;24(6):314-339. doi: 10.1089/omi.2020.0023. OMICS. 2020. PMID: 32496970
-
Cancer associated fibroblasts in cancer development and therapy.J Hematol Oncol. 2025 Mar 28;18(1):36. doi: 10.1186/s13045-025-01688-0. J Hematol Oncol. 2025. PMID: 40156055 Free PMC article. Review.
-
From darkness to light: Targeting CAFs as a new potential strategy for cancer treatment.Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113482. doi: 10.1016/j.intimp.2024.113482. Epub 2024 Oct 29. Int Immunopharmacol. 2024. PMID: 39476569 Review.
-
CAF-mediated tumor vascularization: From mechanistic insights to targeted therapies.Cell Signal. 2025 Aug;132:111827. doi: 10.1016/j.cellsig.2025.111827. Epub 2025 Apr 25. Cell Signal. 2025. PMID: 40288665 Review.
-
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1. Mol Cancer. 2021. PMID: 34635121 Free PMC article. Review.
Cited by
-
Genetic variants of FER and SULF1 in the fibroblast-related genes are associated with non-small-cell lung cancer survival.Int J Cancer. 2025 Jun 1;156(11):2107-2117. doi: 10.1002/ijc.35305. Epub 2024 Dec 20. Int J Cancer. 2025. PMID: 39707607
-
Detecting cell types and densities in the tumor microenvironment improves prognostic risk assessment for breast cancer.Biomol Biomed. 2024 Dec 11;25(1):106-114. doi: 10.17305/bb.2024.10974. Biomol Biomed. 2024. PMID: 39151110 Free PMC article.
-
Therapeutic targets of armored chimeric antigen receptor T cells navigating the tumor microenvironment.Exp Hematol Oncol. 2024 Sep 30;13(1):96. doi: 10.1186/s40164-024-00564-w. Exp Hematol Oncol. 2024. PMID: 39350256 Free PMC article. Review.
-
FOS-driven inflammatory CAFs promote colorectal cancer liver metastasis via the SFRP1-FGFR2-HIF1 axis.Theranostics. 2025 Mar 21;15(10):4593-4613. doi: 10.7150/thno.111625. eCollection 2025. Theranostics. 2025. PMID: 40225580 Free PMC article.
-
Metabolic Adaptations in Cancer Progression: Optimization Strategies and Therapeutic Targets.Cancers (Basel). 2025 Jul 15;17(14):2341. doi: 10.3390/cancers17142341. Cancers (Basel). 2025. PMID: 40723225 Free PMC article. Review.
References
-
- Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. - PubMed
-
- Decoding cancer metastasis Nat Cell Biol 20 8 2018 859 - PubMed
-
- Liang C., Xu L., Song G., Liu Z. Emerging nanomedicine approaches fighting tumor metastasis: animal models, metastasis-targeted drug delivery, phototherapy, and immunotherapy. Chem Soc Rev. 2016;45(22):6250–6269. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials